←
Ryan Potts768 posts
Ryan Potts avatar

Ryan Potts

@pottslab

VP & Head of Induced Proximity Platform, @Amgen | Scientist | Father

◷ Joined January 2014▧ 105 Photos and videos
Ryan Potts avatar
Ryan Potts@pottslab·21 Aug 2025

What if treating disease meant stabilizing biology, not blocking it? We explore that idea in @ScienceMagazine with LOCKTAC molecular glues, a new class of molecules that stabilize natural interactions to either boost or block biology. science.org/doi/10.1126/scie… #mycompnay

AACR avatar
⟳ Ryan Potts retweeted
AACR@AACR·Jul 24

David Puleo, Marina Nelen, Chinatsu Sakata, and Ryan Potts discussed "Degraders in the Era of Precision Oncology" in an #AACRdrugdev26 plenary session chaired by Danette Daniels. @pottslab @danetteldaniels

Post attachment
Kenneth Loi avatar
⟳ Ryan Potts retweeted
Kenneth Loi@kenjmloi·Apr 27

Excited to share our discovery of a new programmable RNA-guided DNA-targeting system hiding inside bacteriophages that predates CRISPR. We call it VIPR (Viral Interference Programmable Repeat), and it uses an entirely new logic to find its targets. Thread + link below.

Post attachment
William Gibson avatar
⟳ Ryan Potts retweeted
William Gibson@wgibson·Mar 28

What if a small molecule could activate a transcription factor program in one cell type and destroy the same pathway in another? In our new preprint, we describe one such story on bifunctional molecules that toggle between transactivation and repression.

Post attachment
biorxiv_biochem avatar
⟳ Ryan Potts retweeted
biorxiv_biochem@biorxiv_biochem·Jan 3

Rescuing the Function of Missense-Mutated Tumor Suppressor VHL using Stabilizing Small Molecules biorxiv.org/content/10.64898… #biorxiv_biochem

bioRxiv Cancer Bio avatar
⟳ Ryan Potts retweeted
bioRxiv Cancer Bio@biorxiv_cancer·Jan 3

Functional inactivation of the telomerase chaperone TCAB1 primes cells for the activation of ALT in osteosarcoma biorxiv.org/content/10.64898… #biorxiv_cancer

bioRxiv Molecular Biology avatar
⟳ Ryan Potts retweeted
bioRxiv Molecular Biology@biorxiv_molbio·30 Nov 2025

Orthosteric Molecular Glue Inhibits COP9 Signalosome with Substrate-Dependent Potency biorxiv.org/content/10.1101/… #biorxiv_molbio

Kaiyi Jiang avatar
⟳ Ryan Potts retweeted
Kaiyi Jiang@idmjky·20 Sep 2025

Thrilled to share that I have joined @Amgen as the inaugural Amgen Science Fellow. I look forward to partnering with colleagues to design next-gen therapeutic by integrating AI/ML with high throughput synthetic biology platforms. linkedin.com/posts/drhoward-…

Itai Yanai avatar
⟳ Ryan Potts retweeted
Itai Yanai@ItaiYanai·7 Sep 2025

Legend David Baltimore died yesterday. He understood the way things should work: "the real contribution of @MIT is that it doesn't take itself too seriously. It takes ideas seriously, but the people are relatively informal. They are not self-aggrandizing the way academics can be.

Post attachment
KaelinLab avatar
⟳ Ryan Potts retweeted
KaelinLab@kaelin_lab·28 Aug 2025

Thrilled to share our work to find natural products that inhibit β-catenin! This is the result of an amazing collaboration with @theNCI Natural Products Branch and shows the power of 'up' assays to find new and interesting molecules! biorxiv.org/content/10.1101/…

Ventura's Lab avatar
⟳ Ryan Potts retweeted
Ventura's Lab@PPMC_UAB·22 Aug 2025

Great to see our two in-house developed kinetic stabilizers, Tolcapone and PITB, against transthyretin amyloidoses cited as examples of an emerging therapeutic class: LOCKTACS. science.org/doi/10.1126/scie…